| Name | Title | Contact Details |
|---|
Cranetech is a Arkport, NY-based company in the Business Services sector.
Fishers Auctn & Appraisal Svcs is a Edgewater, FL-based company in the Business Services sector.
R4 Solutions Inc, based in Cupertino, California, is a healthcare IT service organization founded in 2008. The company employs around 214 people and generates approximately $15.6 million in revenue. R4 specializes in providing technology solutions tailored for healthcare organizations, including IT consulting, software development, and infrastructure optimization. The company is recognized for its positive work culture, boasting a 99% employee approval rating. R4 offers a range of services, including custom software development, application implementation, and maintenance, all aimed at enhancing IT infrastructure for healthcare providers. They also focus on cybersecurity, ensuring the protection of sensitive healthcare data through proactive threat prevention and compliance safeguards. Additionally, R4 provides database management services to optimize data governance and efficiency, along with consulting services that support digital transformation and process improvement in healthcare IT. With a strong emphasis on customer-centric practices and a team of credentialed consultants, R4 Solutions is dedicated to delivering high-quality solutions that meet the unique needs of healthcare organizations.
Modern Portfolio Management is a Maumee, OH-based company in the Business Services sector.
Kapadi (former OncoBay, Clinscience and Exom) delivers specialized biotech Contract Research Organization (CRO) services, expertly navigating the intricacies of early-stage drug development. We harness state-of-the-art technology solutions and advanced data visualization to propel operational and data excellence. Our teams unwavering dedication to the field is evident, with each member bringing deep expertise in oncology, and pioneering areas like gene and cell therapy. At Kapadi, were committed to accelerating the breakthroughs that will shape the future of cancer treatment.